CMH — Chordate Medical Holding AB (publ) Income Statement
0.000.00%
- SEK30.65m
- SEK10.21m
- SEK0.98m
Annual income statement for Chordate Medical Holding AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | SAS | SAS | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1.16 | 0.618 | 0.882 | 0.109 | 0.976 |
Cost of Revenue | |||||
Gross Profit | 2.07 | 2.51 | 1.93 | 0.034 | 1.31 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 25.7 | 20 | 22.6 | 28.1 | 30.5 |
Operating Profit | -24.5 | -19.4 | -21.7 | -28 | -29.6 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -24.9 | -19.8 | -21.8 | -27.9 | -29.2 |
Net Income After Taxes | -24.9 | -19.8 | -21.8 | -27.9 | -29.2 |
Net Income Before Extraordinary Items | |||||
Net Income | -24.9 | -19.8 | -21.8 | -27.9 | -29.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -24.9 | -19.8 | -21.8 | -27.9 | -29.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.488 | -0.217 | -0.093 | -0.135 | -0.095 |
Dividends per Share |